Live Breaking News & Updates on Helena Edlund

Stay updated with breaking news from Helena edlund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amplifier Therapeutics Raises Additional Funding in Series A

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Helena Edlund , James Hall , Thomas Edlund , Olof Karlsson , European Union , Amplifier Therapeutics , Future Ventures , Amplifier Series , Cambrian Bio ,

Cambrian Biopharma: Cambrian Bio launches Amplifier Therapeutics to develop clinical-stage AMPK activator

The New York based biotech company announces launch of Amplifier Therapeutics to develop the clinical stage pan-AMPK activator, ATX-304 NEW YORK, March 14, 2023 /PRNewswire/ Cambrian ....

New York , United States , Dennis Riedl , Thomas Edlund , James Peyer , Helena Edlund , Ruth Thieroff Ekerdt , James Hall , Olof Karlsson , Rosa Argyropoulos , Head Of Cardiovascular Business Development At Astrazeneca , A Distributed Development Company , Global Corporate Communications , Clinical Development , Amplifier Therapeutics , Cardiovascular Business Development , Mechanism Phase , Distributed Development Company , Global Corporate ,

Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice

/PRNewswire/ Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena. ....

James Hall , Alice Wallenbergs Stiftelse , Familjen Erling Perssons , Helena Edlund , Centre For Molecular Medicine , Scientific Reports , Molecular Medicine , Heart Failure , Renal Disease , Betagenon Ab ,

Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice

/PRNewswire/ Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena. ....

James Hall , Alice Wallenbergs Stiftelse , Familjen Erling Perssons , Helena Edlund , Centre For Molecular Medicine , Scientific Reports , Molecular Medicine , Heart Failure , Renal Disease , Betagenon Ab ,

Betagenon AB: Betagenon co-founder publishes that AMPK activator O304 prevents gene expression changes and remobilisation of histone marks in islets of diet-induced obese mice

STOCKHOLM, Dec. 23, 2021 /PRNewswire/ Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Helena Edlund ....

James Hall , Kostenloser Wertpapierhandel , Alice Wallenbergs Stiftelse , Familjen Erling Perssons , Helena Edlund , Centre For Molecular Medicine , Scientific Reports , Molecular Medicine , Heart Failure , Renal Disease ,